Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BTAI

BioXcel Therapeutics

$5.93

0.3 (5.33%)

07:10
11/09/18
11/09
07:10
11/09/18
07:10
Earnings
BioXcel Therapeutics reports Q3 EPS (31c), consensus (29c) »

As of September 30, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

BTAI

BioXcel Therapeutics

$5.52

-0.04 (-0.72%)

05:37
11/05/18
11/05
05:37
11/05/18
05:37
Hot Stocks
BioXcel Therapeutics announces FDA acceptance of IND for BXCL701 »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

BTAI

BioXcel Therapeutics

$5.23

-0.05 (-0.95%)

04:55
11/01/18
11/01
04:55
11/01/18
04:55
Conference/Events
BioXcel Therapeutics management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

BTAI

BioXcel Therapeutics

$5.01

-0.05 (-0.99%)

11:20
10/30/18
10/30
11:20
10/30/18
11:20
Conference/Events
BioXcel Therapeutics management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTAI

BioXcel Therapeutics

$5.06

-0.58 (-10.28%)

05:25
10/30/18
10/30
05:25
10/30/18
05:25
Hot Stocks
BioXcel says on track to initiate BXCL501 first-in-human PK and safety study »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
NLNK

NewLink Genetics

$2.24

-0.01 (-0.44%)

, MRK

Merck

$71.80

0.57 (0.80%)

04:55
10/18/18
10/18
04:55
10/18/18
04:55
Conference/Events
Biotechnology Innovation Organization to hold a forum »

2018 BIO Investor Forum…

NLNK

NewLink Genetics

$2.24

-0.01 (-0.44%)

MRK

Merck

$71.80

0.57 (0.80%)

ABBV

AbbVie

$92.21

0.32 (0.35%)

BTAI

BioXcel Therapeutics

$6.58

0.21 (3.30%)

SMMT

Summit Therapeutics

$1.87

-0.03 (-1.58%)

XOMA

Xoma

$16.03

-0.02 (-0.12%)

RDY

Dr. Reddy's

$34.62

-0.615 (-1.75%)

INFI

Infinity Pharmaceuticals

$2.65

0.07 (2.71%)

VVUS

VIVUS

$4.58

-0.07 (-1.51%)

LLY

Eli Lilly

$113.59

2.56 (2.31%)

BMY

Bristol-Myers

$58.91

1.1 (1.90%)

ZSAN

Zosano Pharma

$4.02

-0.02 (-0.50%)

AXSM

Axsome Therapeutics

$3.95

0.5 (14.49%)

IMV

IMV Inc

$5.45

(0.00%)

AMZN

Amazon.com

$1,832.81

14.81 (0.81%)

DFFN

Diffusion Pharmaceuticals

$0.42

0.035 (9.21%)

CLBS

Caladrius

$4.53

-0.12 (-2.58%)

ONTX

Onconova

$6.05

-0.31 (-4.87%)

NAVB

Navidea

$0.30

-0.0341 (-10.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 29

    Oct

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 11

    Jan

  • 16

    Feb

NLNK

NewLink Genetics

$2.25

0.08 (3.69%)

, MRK

Merck

$71.23

1.77 (2.55%)

08:08
10/17/18
10/17
08:08
10/17/18
08:08
Conference/Events
Biotechnology Innovation Organization to hold a forum »

2018 BIO Investor Forum…

NLNK

NewLink Genetics

$2.25

0.08 (3.69%)

MRK

Merck

$71.23

1.77 (2.55%)

ABBV

AbbVie

$91.89

2.69 (3.02%)

BTAI

BioXcel Therapeutics

$6.37

0.24 (3.92%)

SMMT

Summit Therapeutics

$1.90

0.05 (2.70%)

XOMA

Xoma

$16.05

0.88 (5.80%)

RDY

Dr. Reddy's

$35.23

0.77 (2.23%)

INFI

Infinity Pharmaceuticals

$2.58

0.11 (4.45%)

VVUS

VIVUS

$4.65

0.05 (1.09%)

LLY

Eli Lilly

$111.03

0.34 (0.31%)

BMY

Bristol-Myers

$57.81

0.22 (0.38%)

ZSAN

Zosano Pharma

$4.04

0.08 (2.02%)

AXSM

Axsome Therapeutics

$3.45

0.11 (3.29%)

IMV

IMV Inc

$5.45

(0.00%)

AMZN

Amazon.com

$1,818.00

57.01 (3.24%)

DFFN

Diffusion Pharmaceuticals

$0.38

0.005 (1.33%)

CLBS

Caladrius

$4.65

0.05 (1.09%)

ONTX

Onconova

$6.36

0.44 (7.43%)

NAVB

Navidea

$0.33

-0.0084 (-2.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 29

    Oct

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 11

    Jan

  • 16

    Feb

BTAI

BioXcel Therapeutics

$7.01

-0.52 (-6.91%)

07:11
10/08/18
10/08
07:11
10/08/18
07:11
Hot Stocks
BioXcel Therapeutics submits IND application for BXCL701 »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTAI

BioXcel Therapeutics

$7.50

-0.09 (-1.19%)

, NKTR

Nektar

$59.00

0.53 (0.91%)

07:25
09/24/18
09/24
07:25
09/24/18
07:25
Hot Stocks
BioXcel Therapeutics, Nektar expand research collaboration into partnership »

BioXcel Therapeutics…

BTAI

BioXcel Therapeutics

$7.50

-0.09 (-1.19%)

NKTR

Nektar

$59.00

0.53 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTAI

BioXcel Therapeutics

$8.00

-0.03 (-0.37%)

08:05
08/22/18
08/22
08:05
08/22/18
08:05
Hot Stocks
BioXcel Therapeutics forms CAB to further develop BXCL701 »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.